Real-time enrollment status for this immune thrombocytopenia clinical trial
Current Status
Recruiting
Checked: October 12, 2026 at 1:01 PM UTC
| NCT Number | NCT07104565 |
| Recruiting Status | Recruiting |
| Condition | Immune Thrombocytopenia |
| Phase | PHASE2 |
| Target Enrollment | 56 participants |
| Active Locations | 9 sites in the US |
| Sponsor | Incyte Corporation |
| Last Updated on CT.gov | September 14, 2026 (4 weeks ago) |
As of October 12, 2026: Clinical trial NCT07104565 is currently recruiting participants. This phase2 study for immune thrombocytopenia is actively seeking new participants at 9 locations across the United States. The study is sponsored by Incyte Corporation. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07104565 is actively recruiting participants as of October 12, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 9 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07104565 was last updated 4 weeks ago (September 14, 2026). HelloStudys verifies this status automatically.